/PRNewswire/ -- 律师事务所 Robbins Geller Rudman &amp; Dowd LLP 宣布，在 2025 年 2 月 5 日至 2025 年 7 月 23 日（包括这两个日期）期间购买或获得 Molina Healthcare, Inc. (NYSE: MOH) 证券的投资者，有直到 2025 年 12 月 2 日的时间申请成为 Molina 集体诉讼的首席原告。该案件标题为 Hindlemann v. Molina Healthcare, Inc., No. 25-cv-09461 (C.D. Cal.)，指控 Molina Healthcare 及其部分高管违反了 1934 年证券交易法。
如果您遭受了重大损失并希望担任 Molina Healthcare 集体诉讼的首席原告，请在此提供您的信息：
https://www.rgrdlaw.com/cases-molina-healthcare-inc-class-action-lawsuit-moh.html
您也可以通过拨打 800/449-4900 或发送电子邮件至 [email protected] 联系 Robbins Geller 的律师 J.C. Sanchez 或 Jennifer N. Caringal。
案件指控：Molina Healthcare 为低收入家庭和个人提供管理医疗服务，涵盖 Medicaid 和 Medicare 项目以及州保险市场。
Molina Healthcare 集体诉讼指控被告在整个诉讼期间未能披露：(i) 关于 Molina Healthcare 的 “医疗成本趋势假设” 的重要不利事实；(ii) Molina Healthcare 正在经历 “保费率与医疗成本趋势之间的失衡”；(iii) Molina Healthcare 的短期增长依赖于缺乏 “行为健康、药房以及住院和门诊服务的使用”；以及 (iv) 因此，Molina Healthcare 对 2025 财年的财务指引很可能会大幅下调。
Molina Healthcare 集体诉讼进一步指控，2025 年 7 月 7 日，Molina Healthcare 披露了 2025 年第二季度调整后每股收益约为 5.50 美元，低于其先前预期，原因是 “三个业务线的医疗成本压力”。Molina Healthcare 还披露 “预计这些医疗成本压力将持续到下半年”，并在中点上将预期调整后每股收益指引下调 10.2%，并且正在经历来自 “保费率与医疗成本趋势之间的失衡的短期收益压力，该失衡最近加剧”，投诉中指出。根据投诉，这一消息导致 Molina Healthcare 股票价格下跌。
然后，Molina Healthcare 集体诉讼指控，2025 年 7 月 23 日，Molina Healthcare 报告了截至 2025 年 6 月 30 日的第二季度财务结果，并进一步下调了 2025 年全年的收益指引。在此过程中，Molina Healthcare 披露 “2025 年第二季度的 GAAP 净收入为每稀释股 4.75 美元，同比下降 8%”，并且 “现在预计 2025 年全年的调整后每股收益不低于 19.00 美元”，Molina Healthcare 集体诉讼称。Molina Healthcare 据称将其结果和全年展望归因于 “具有挑战性的医疗成本趋势环境”，包括 “行为健康、药房以及住院和门诊服务的使用”。根据投诉，这一消息导致 Molina Healthcare 股票价格下跌近 17%。
首席原告流程：1995 年《私人证券诉讼改革法》允许在集体诉讼期间购买或获得 Molina Healthcare 证券的任何投资者申请成为 Molina Healthcare 集体诉讼的首席原告。首席原告通常是寻求救济的潜在集体中财务利益最大的动议者，同时也是潜在集体的典型和适当代表。首席原告代表所有其他集体成员指导 Molina Healthcare 集体诉讼。首席原告可以选择其选择的律师事务所来进行 Molina Healthcare 集体诉讼。投资者分享任何潜在未来赔偿的能力并不依赖于担任 Molina Healthcare 集体诉讼的首席原告。
关于 ROBBINS GELLER：Robbins Geller Rudman &amp; Dowd LLP 是全球领先的律师事务所之一，代表投资者进行证券欺诈和股东诉讼。我们的事务所过去五年中有四年在 ISS 证券集体诉讼服务排名中被评为第一，因为为投资者争取到最多的货币救济。在 2024 年，我们为证券相关集体诉讼案件为投资者追回了超过 25 亿美元的赔偿——根据 ISS，这一金额超过了接下来五家律师事务所的总和。Robbins Geller 拥有 200 名律师，设有 10 个办公室，是全球最大的原告律师事务所之一，事务所的律师获得了历史上许多最大的证券集体诉讼赔偿，包括最大的一笔——72 亿美元——在 In re Enron Corp. Sec. Litig. 案件中。有关更多信息，请访问以下页面：
https://www.rgrdlaw.com/services-litigation-securities-fraud.html
过去的结果并不保证未来的结果。
服务可能由我们任何办公室的律师提供。
联系方式：
Robbins Geller Rudman &amp; Dowd LLP
J.C. Sanchez, Jennifer N. Caringal
655 W. Broadway, Suite 1900, San Diego, CA 92101
800-449-4900
[email protected]
来源 Robbins Geller Rudman &amp; Dowd LLP
<img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDA3Jk5ld3NJdGVtSWQ9TEE5MTcyNiZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMDcwNTUwUFJfTkVXU19VU1BSX19fX19MQTkxNzI2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDA3Jk5ld3NJdGVtSWQ9TEE5MTcyNiZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMDcwNTUwUFJfTkVXU19VU1BSX19fX19MQTkxNzI2"/>

Molina医疗

Robbins Geller Rudman & Dowd LLP 宣布，Molina Healthcare, Inc.（纽约证券交易所代码：MOH）的投资者如果在 2025 年 2 月 5 日至 2025 年 7 月 23 日期间遭受重大损失，可以寻求领导集体诉讼。该诉讼指控违反了 1934 年证券交易法，提到关于 Molina 财务健康和医疗成本趋势的未披露不利事实。在令人失望的财报发布后，Molina 的股价大幅下跌。感兴趣的投资者必须在 2025 年 12 月 2 日之前申请，以便被考虑作为主要原告

, /PRNewswire/ -- The law firm of Robbins Geller Rudman &amp; Dowd LLP announces that purchasers or acquirers of Molina Healthcare, Inc. (NYSE: MOH) securities between February 5, 2025 and July 23, 2025, both dates inclusive (the &#34;Class Period&#34;), have until December 2, 2025 to seek appointment as lead plaintiff of the Molina class action lawsuit. Captioned Hindlemann v. Molina Healthcare, Inc., No. 25-cv-09461 (C.D. Cal.), the Molina Healthcare class action lawsuit charges Molina Healthcare and certain of Molina Healthcare's top executives with violations of the Securities Exchange Act of 1934.
<div class="lb-trans">/PRNewswire/ -- 律师事务所 Robbins Geller Rudman &amp; Dowd LLP 宣布，在 2025 年 2 月 5 日至 2025 年 7 月 23 日（包括这两个日期）期间购买或获得 Molina Healthcare, Inc. (NYSE: MOH) 证券的投资者，有直到 2025 年 12 月 2 日的时间申请成为 Molina 集体诉讼的首席原告。该案件标题为 Hindlemann v. Molina Healthcare, Inc., No. 25-cv-09461 (C.D. Cal.)，指控 Molina Healthcare 及其部分高管违反了 1934 年证券交易法。
</div>If you suffered substantial losses and wish to serve as lead plaintiff of the Molina Healthcare class action lawsuit, please provide your information here:
<div class="lb-trans">如果您遭受了重大损失并希望担任 Molina Healthcare 集体诉讼的首席原告，请在此提供您的信息：
</div>https://www.rgrdlaw.com/cases-molina-healthcare-inc-class-action-lawsuit-moh.html
<div class="lb-trans">https://www.rgrdlaw.com/cases-molina-healthcare-inc-class-action-lawsuit-moh.html
</div>You can also contact attorneys J.C. Sanchez or Jennifer N. Caringal of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected].
<div class="lb-trans">您也可以通过拨打 800/449-4900 或发送电子邮件至 [email protected] 联系 Robbins Geller 的律师 J.C. Sanchez 或 Jennifer N. Caringal。
</div>CASE ALLEGATIONS: Molina Healthcare provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces.
<div class="lb-trans">案件指控：Molina Healthcare 为低收入家庭和个人提供管理医疗服务，涵盖 Medicaid 和 Medicare 项目以及州保险市场。
</div>The Molina Healthcare class action lawsuit alleges that defendants throughout the Class Period failed to disclose: (i) material, adverse facts concerning Molina Healthcare's &#34;medical cost trend assumptions&#34;; (ii) that Molina Healthcare was experiencing a &#34;dislocation between premium rates and medical cost trend&#34;; (iii) that Molina Healthcare's near term growth was dependent on a lack of &#34;utilization of behavioral health, pharmacy, and inpatient and outpatient services&#34;; and (iv) as a result, Molina Healthcare's financial guidance for fiscal year 2025 was substantially likely to be cut.
<div class="lb-trans">Molina Healthcare 集体诉讼指控被告在整个诉讼期间未能披露：(i) 关于 Molina Healthcare 的 “医疗成本趋势假设” 的重要不利事实；(ii) Molina Healthcare 正在经历 “保费率与医疗成本趋势之间的失衡”；(iii) Molina Healthcare 的短期增长依赖于缺乏 “行为健康、药房以及住院和门诊服务的使用”；以及 (iv) 因此，Molina Healthcare 对 2025 财年的财务指引很可能会大幅下调。
</div>The Molina Healthcare class action lawsuit further alleges that on July 7, 2025, Molina Healthcare revealed second quarter 2025 adjusted earnings of approximately $5.50 per share, which was &#34;below its prior expectations&#34; due to &#34;medical cost pressures in all three lines of business.&#34; Molina Healthcare also disclosed that it &#34;expects these medical cost pressures to continue into the second half of the year,&#34; cut guidance for expected adjusted earnings per share 10.2% at the midpoint, and that it was experiencing a &#34;short-term earnings pressure&#34; from a &#34;dislocation between premium rates and medical cost trend which has recently accelerated,&#34; the complaint alleges. On this news, the price of Molina Healthcare stock fell, according to the complaint.
<div class="lb-trans">Molina Healthcare 集体诉讼进一步指控，2025 年 7 月 7 日，Molina Healthcare 披露了 2025 年第二季度调整后每股收益约为 5.50 美元，低于其先前预期，原因是 “三个业务线的医疗成本压力”。Molina Healthcare 还披露 “预计这些医疗成本压力将持续到下半年”，并在中点上将预期调整后每股收益指引下调 10.2%，并且正在经历来自 “保费率与医疗成本趋势之间的失衡的短期收益压力，该失衡最近加剧”，投诉中指出。根据投诉，这一消息导致 Molina Healthcare 股票价格下跌。
</div>Then, the Molina Healthcare class action lawsuit alleges that on July 23, 2025 Molina Healthcare reported its financial results for the second quarter ended June 30, 2025 and further cut its full-year 2025 earnings guidance. In doing so, Molina Healthcare revealed that &#34;GAAP net income was $4.75 per diluted share for the second quarter of 2025, a decrease of 8% year over year&#34; and it &#34;now expects its full year 2025 adjusted earnings to be no less than $19.00 per diluted share,&#34; the Molina Healthcare class action alleges. Molina Healthcare allegedly attributed its results and full year outlook to a &#34;challenging medical cost trend environment,&#34; including &#34;utilization of behavioral health, pharmacy, and inpatient and outpatient services.&#34; On this news, the price of Molina Healthcare stock fell nearly 17%, according to the complaint.
<div class="lb-trans">然后，Molina Healthcare 集体诉讼指控，2025 年 7 月 23 日，Molina Healthcare 报告了截至 2025 年 6 月 30 日的第二季度财务结果，并进一步下调了 2025 年全年的收益指引。在此过程中，Molina Healthcare 披露 “2025 年第二季度的 GAAP 净收入为每稀释股 4.75 美元，同比下降 8%”，并且 “现在预计 2025 年全年的调整后每股收益不低于 19.00 美元”，Molina Healthcare 集体诉讼称。Molina Healthcare 据称将其结果和全年展望归因于 “具有挑战性的医疗成本趋势环境”，包括 “行为健康、药房以及住院和门诊服务的使用”。根据投诉，这一消息导致 Molina Healthcare 股票价格下跌近 17%。
</div>THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired Molina Healthcare securities during the Class Period to seek appointment as lead plaintiff in the Molina Healthcare class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the Molina Healthcare class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the Molina Healthcare class action lawsuit. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Molina Healthcare class action lawsuit.
<div class="lb-trans">首席原告流程：1995 年《私人证券诉讼改革法》允许在集体诉讼期间购买或获得 Molina Healthcare 证券的任何投资者申请成为 Molina Healthcare 集体诉讼的首席原告。首席原告通常是寻求救济的潜在集体中财务利益最大的动议者，同时也是潜在集体的典型和适当代表。首席原告代表所有其他集体成员指导 Molina Healthcare 集体诉讼。首席原告可以选择其选择的律师事务所来进行 Molina Healthcare 集体诉讼。投资者分享任何潜在未来赔偿的能力并不依赖于担任 Molina Healthcare 集体诉讼的首席原告。
</div>ABOUT ROBBINS GELLER: Robbins Geller Rudman &amp; Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:
<div class="lb-trans">关于 ROBBINS GELLER：Robbins Geller Rudman &amp; Dowd LLP 是全球领先的律师事务所之一，代表投资者进行证券欺诈和股东诉讼。我们的事务所过去五年中有四年在 ISS 证券集体诉讼服务排名中被评为第一，因为为投资者争取到最多的货币救济。在 2024 年，我们为证券相关集体诉讼案件为投资者追回了超过 25 亿美元的赔偿——根据 ISS，这一金额超过了接下来五家律师事务所的总和。Robbins Geller 拥有 200 名律师，设有 10 个办公室，是全球最大的原告律师事务所之一，事务所的律师获得了历史上许多最大的证券集体诉讼赔偿，包括最大的一笔——72 亿美元——在 In re Enron Corp. Sec. Litig. 案件中。有关更多信息，请访问以下页面：
</div>https://www.rgrdlaw.com/services-litigation-securities-fraud.html
<div class="lb-trans">https://www.rgrdlaw.com/services-litigation-securities-fraud.html
</div>Past results do not guarantee future outcomes.
<div class="lb-trans">过去的结果并不保证未来的结果。
</div>Services may be performed by attorneys in any of our offices.
<div class="lb-trans">服务可能由我们任何办公室的律师提供。
</div>Contact:
<div class="lb-trans">联系方式：
</div>Robbins Geller Rudman &amp; Dowd LLP
<div class="lb-trans">Robbins Geller Rudman &amp; Dowd LLP
</div>J.C. Sanchez, Jennifer N. Caringal
<div class="lb-trans">J.C. Sanchez, Jennifer N. Caringal
</div>655 W. Broadway, Suite 1900, San Diego, CA 92101
<div class="lb-trans">655 W. Broadway, Suite 1900, San Diego, CA 92101
</div>800-449-4900
<div class="lb-trans">800-449-4900
</div>[email protected]
<div class="lb-trans">[email protected]
</div>SOURCE Robbins Geller Rudman &amp; Dowd LLP
<div class="lb-trans">来源 Robbins Geller Rudman &amp; Dowd LLP
</div><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjUxMDA3Jk5ld3NJdGVtSWQ9TEE5MTcyNiZUcmFuc21pc3Npb25fSWQ9MjAyNTEwMDcwNTUwUFJfTkVXU19VU1BSX19fX19MQTkxNzI2" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA91726&amp;Transmission_Id=202510070550PR_NEWS_USPR_____LA91726&amp;DateId=20251007"/>

05:50 ET
			
			
				MOH INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Molina Healthcare, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

MOH 投资者通知：Robbins Geller Rudman & Dowd LLP 宣布，Molina Healthcare, Inc.的投资者如果遭受重大损失，有机会主导集体诉讼